A study has found that 7 determinants of ideal cardiovascular health are also associated with slowing down the decline in cognitive performance in multiethnic population.
The American Heart Association (AHA) initially defined smoking, body mass index (BMI), physical activity, diet, blood pressure, cholesterol, and glucose as determinants to an ideal cardiovascular health (CVH). However, a new study finds that these CVH factors are not limited to determining only the health of the heart. The 7 CVH metrics are also associated with slowing down the decline in cognitive performance in multiethnic population.
The AHA has established a direct relationship between the pre-defined 7 metrics and cardiovascular disease morbidity and mortality. It aims to improve CVH for all Americans by 20% by measuring progress of the metrics.
The new study, published in Journal of the American Heart Association, goes beyond heart diseases and strokes. Hannah Gardener, ScD, and fellow authors suggest that the CVH metrics are also responsible for altering cognitive aging and lead to decline of cognitive impairment in patients with neurocognitive disorders. The study aims to establish clear connections between the CVH metrics and less decline in cognitive performance.
Study Process
Northern Manhattan Study (NOMAS) is designed to determine risk factors for stroke among a racially diverse urban population. A subsample (made up of 63% Hispanic, 20% nonâ€Hispanic black, and 15% nonâ€Hispanic white residents) from NOMAS underwent repeated neuropsychological testing. All participants were older than 40 years and had never been diagnosed with a stroke.
The 4 domains of cognitive performance compared based on initial performance and decline over time were Episodic Memory, Semantic Memory, Executive Function, and Processing Speed.
The results were as follows:
What It Means
The more the number of ideal CVH factors, better was the processing speed at initial assessment and less decline. This association was strongest for 3 of the CVH factors in particular: ideal BMI, lack of smoking, and ideal fasting glucose. When the levels of these 3 factors were ideal, the cognitive performance was better at initial assessment.
“Our data suggests that promoting ideal CVH on even a few of these factors may result in cognitive health benefits,” Dr Gardener said.
The study also highlights that the lack of ideal factors—high blood pressure, glucose, cholesterol, and BMI; poor and unhealthy diet; lack of physical activity; and smoking during adulthood—lead to impaired performance on neurocognitive assessments, as well as with decline in performance over time.
The study provides evidence that maintaining an ideal level for all the 7 CVH factors not only helps the heart, but also the brain.
“As the US population ages and the number of people at risk for cognitive impairment grows, the public health implications of targeting these modifiable risk factors will be substantial,” the study concluded.
BRCA-Like Classification May Be a Useful Biomarker for Olaparib Response in Ovarian Cancer
May 1st 2024Adding olaparib to maintenance therapy with bevacizumab was associated with significantly longer survival for patients with ovarian cancer whose tumors have a BRCA-like genomic profile, but not among those with non-BRCA-like tumors, a study found.
Read More
The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department of Agriculture (USDA) will begin testing ground beef for bird flu particles; rural Americans are more likely to die early from 1 of the 5 leading causes of death than those who live in urban areas.
Read More
Bimekizumab Shows Sustained Efficacy in Treating Axial Spondyloarthritis for 52 Weeks
April 30th 2024Results from a study presented at the Academy of Managed Care Pharmacy 2024 annual meeting demonstrated sustained efficacy of bimekizumab compared with placebo in patients with non-radiographic and radiographic axial spondyloarthritis (axSpA) at week 52.
Read More